Dec 04, 2024
Rgenta Therapeutics Announces Strategic Alliance with GSK to Develop RNA-Targeted Small Molecule Splice Modulators
Sep 16, 2024
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
Dec 17, 2020
LRA Pleased to Share GSK's Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA
Oct 28, 2020
Malawi becomes the second country in sub-Saharan Africa to eliminate lymphatic filariasis (elephantiasis)
Sep 16, 2020
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® for Lupus Nephritis
Aug 24, 2020
Low adult immunization rates decline further due to pandemic
Jul 28, 2020
GSK begins shipping record number of its influenza vaccine doses for 2020-21 season for US market
Jan 16, 2020
Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People
Dec 18, 2019
GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis
Dec 18, 2019
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
Aug 27, 2019
Ionis licenses hepatitis B program to GSK
Jul 15, 2019
GSK ships 2019-20 seasonal influenza vaccines for US market
Apr 26, 2019
GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above
Feb 22, 2019
British investigators drop probes on Rolls-Royce, GSK
Feb 22, 2019
Affaires Rolls-Royce et GSK: les autorités britanniques renoncent aux poursuites
Dec 06, 2018
Fimbrion and GSK Identify Novel, Antibiotic-Sparing Development Candidate for Urinary Tract Infections
Aug 08, 2018
GSK ships 2018-19 seasonal influenza vaccines for US market
Jan 12, 2018
GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Nov 14, 2017
New survey shines light on critical gaps in adult vaccination knowledge
Nov 13, 2017
Technical Snapshots for These Drug Makers Stocks -- AstraZeneca, Impax Laboratories, TherapeuticsMD, and GlaxoSmithKline